Event
Singapore Life Sciences Roundtable
Wednesday, September 3, 2025
This intimate, industry-focused session will bring together legal and compliance professionals from multinational pharmaceutical, medtech, and biotech companies to explore how recent global developments are reshaping the regulatory and transactional landscape across Asia-Pacific.
Topics include:
- The New DOJ White Collar Enforcement Playbook
What it means for APAC operations and compliance functions - The New U.S. Administration and the FDA
Taking stock of paradigm-shifting developments in drug and device regulation - Life Sciences Transactions in APAC
Navigating deal risks, regulatory scrutiny, and cross-border trends
PROGRAM
Registration and Refreshments: 9:30 a.m. – 10:00 a.m. SGT
Sidley Presentation and Roundtable Dialogue: 10:00 a.m. – 12:00 p.m. SGT
Networking Lunch: 12:00 p.m. – 1:00 p.m. SGT
For questions or more information, please contact asiaevents@sidley.com.
Contacts
Offices
Capabilities
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Represents GSK in Connection With Its €3.5 Billion Issuance of NotesSeptember 17, 2026HHS Secretary Announces Intent to Extend HHS-OIG Exclusion Authority to CMS, Expanding the Administration’s Anti-Fraud CampaignSeptember 16, 2026FDA and SEC Announce Coordination on Scrutiny of Public DisclosuresSeptember 16, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

